• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Medivation, Inc. (MDVN)

    -NasdaqGS
    108.82 Up 0.88(0.82%) Jan 30, 4:00PM EST
    |After Hours : 108.87 Up 0.05 (0.05%) Jan 30, 7:04PM EST
    Add to Portfolio
    Prev Close:107.94
    Open:107.25
    Bid:102.00 x 200
    Ask:N/A
    1y Target Est:116.79
    Beta:0.85
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:106.59 - 109.75
    52wk Range:54.37 - 117.23
    Volume:903,482
    Avg Vol (3m):1,096,980
    Market Cap:8.45B
    P/E (ttm):75.41
    EPS (ttm):1.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MDVNUp 0.82%8.45B
    ABTDown 1.10%67.40B
    DNDN 0.00%N/A
    JNJDown 2.19%280.30B

    Key Statistics

    Forward P/E (1 yr):32.58
    P/S (ttm):15.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :2.70
    Quarterly EPS Est (Dec-14) :1.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback